Analyze Diet

Clinical experience with specific immunotherapy to horse dander.

Abstract: This open clinical study was designed to investigate the occurrence of adverse reactions of specific immunotherapy (SIT) with horse dander and to recognize signs of efficacy regarding horse-induced cutaneous and respiratory symptoms. Methods: Twenty-four patients attending our Outpatient Clinic in Huelva (Spain) with horse-induced allergy were selected for receiving a standardized extract of horse dander (Alutard SQ). Results: Local and systemic reactions (five adverse reactions in four patients) were observed during the induction phase of treatment when administering the doses with the highest allergen concentration. Systemic side effects were mild, one immediate case consisting of wheezing and prompt response to treatment and one mild conjunctival hyperemia. Doses were reduced in all cases, and good tolerance to SIT was maintained. The sensitivity of patients to horse dander as assessed by deliberate natural exposure to horse decreased significantly when patients reached maintenance dose: Conjunctivitis symptoms were reduced in all patients, rhinitic symptoms in 93%, asthmatic symptoms in 90%, and cutaneous symptoms in 87% of the patients. Subjective assessment of a patient's allergic disease on a visual analog scale (VAS) showed an improvement. Ninety-five percent of the patients were highly satisfied with the treatment (efficacy, suitability, and troubles). Conclusions: Specific immunotherapy with standardized horse-allergen extract is a safe treatment with the doses of allergen extract administered in the present study. In addition, it seems to have beneficial effects in patients with moderate-severe rhinoconjunctivitis and/or asthma.
Publication Date: 2002-07-12 PubMed ID: 12109529
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigated the safety and effectiveness of a specific immunotherapy using horse dander extract in treating patients with horse-induced allergies. It revealed mild adverse reactions during the treatment’s initial phase but showed significant decrease in symptoms and high patient satisfaction at the end of the study.

Objective and Methodology

  • This research aimed to explore the adverse reactions that may occur from administering specific immunotherapy (SIT) with horse dander and to identify symptoms that indicate its efficacy in treating skin and respiratory issues triggered by exposure to horses.
  • Twenty-four patients with horse-induced allergies from an Outpatient Clinic in Huelva, Spain were selected to receive a standardized extract of horse dander, referred to as Alutard SQ, for their treatment.

Findings of the Study

  • During the induction phase, where patients were given doses with the highest allergen concentration, five adverse reactions were observed in four patients.
  • The systemic side effects included one immediate case of wheezing that responded promptly to treatment and one case of mild eye redness or conjunctival hyperemia.
  • The doses were reduced for all patients which resulted in overall good tolerance to SIT.
  • Patients’ sensitivity to horse dander, evaluated by deliberate exposure to horse dander, greatly reduced once patients reached the maintenance dose.
  • Improvement reflected through the significant reduction of conjunctivitis among all patients, rhinitis in 93% of patients, asthma in 90% of patients, and skin symptoms in 87% of patients.

Patient Reaction and Outcome

  • Patient assessment of their allergic conditions using a visual analog scale (VAS) showed significant improvement post-treatment.
  • 95% of the patients were highly satisfied with the treatment in terms of its effectiveness, suitability, and minimal complications.

Conclusion and Implications

  • The research concluded that specific immunotherapy with standardized horse dander extract is a safe treatment option based on the doses administered in this study.
  • The treatment showed positive effects for patients with moderate-severe rhinoconjunctivitis and/or asthma, suggesting potential benefits of the therapy for such conditions.

Cite This Article

APA
Fernández-Távora L, Rico P, Martín S. (2002). Clinical experience with specific immunotherapy to horse dander. J Investig Allergol Clin Immunol, 12(1), 29-33.

Publication

ISSN: 1018-9068
NlmUniqueID: 9107858
Country: Spain
Language: English
Volume: 12
Issue: 1
Pages: 29-33

Researcher Affiliations

Fernández-Távora, Laureano
  • Ambulatorio Virgen de la Cinta, Huelva, Spain. laureano2000@terra.es
Rico, Pilar
    Martín, Santiago

      MeSH Terms

      • Adolescent
      • Adult
      • Allergens / adverse effects
      • Allergens / therapeutic use
      • Animals
      • Asthma / immunology
      • Asthma / therapy
      • Child
      • Conjunctivitis, Allergic / immunology
      • Conjunctivitis, Allergic / therapy
      • Female
      • Glycoproteins / adverse effects
      • Glycoproteins / therapeutic use
      • Horses / immunology
      • Humans
      • Immunotherapy / adverse effects
      • Lipocalins
      • Male
      • Rhinitis, Allergic, Perennial / immunology
      • Rhinitis, Allergic, Perennial / therapy
      • Treatment Outcome

      Citations

      This article has been cited 4 times.
      1. Mühlmeier G, Polk ML, Tisch M, Cuevas M. [Allergen immunotherapy for rare allergens]. HNO 2024 Sep;72(9):626-632.
        doi: 10.1007/s00106-024-01469-0pubmed: 38639764google scholar: lookup
      2. Alvaro-Lozano M, Akdis CA, Akdis M, Alviani C, Angier E, Arasi S, Arzt-Gradwohl L, Barber D, Bazire R, Cavkaytar O, Comberiati P, Dramburg S, Durham SR, Eifan AO, Forchert L, Halken S, Kirtland M, Kucuksezer UC, Layhadi JA, Matricardi PM, Muraro A, Ozdemir C, Pajno GB, Pfaar O, Potapova E, Riggioni C, Roberts G, Rodríguez Del Río P, Shamji MH, Sturm GJ, Vazquez-Ortiz M. EAACI Allergen Immunotherapy User's Guide. Pediatr Allergy Immunol 2020 May;31 Suppl 25(Suppl 25):1-101.
        doi: 10.1111/pai.13189pubmed: 32436290google scholar: lookup
      3. Vidal C, Enrique E, Gonzalo A, Moreno C, Tabar AI. Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: an Allergists' Consensus. Clin Transl Allergy 2014;4:36.
        doi: 10.1186/2045-7022-4-36pubmed: 25699172google scholar: lookup
      4. Gawlik R, Pitsch T, Dubuske L. Anaphylaxis as a manifestation of horse allergy. World Allergy Organ J 2009 Aug;2(8):185-9.
        doi: 10.1097/WOX.0b013e3181b2fe51pubmed: 23283110google scholar: lookup